Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Topical IKKα inhibitors may help prevent CCS tumours.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Improved CRBN ligands make protein degraders more effective and drug-like.

The new assay can help develop products for hair re-growth.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.